7 minutes | Thursday, August 27, 2026
The FDA recently approved Rasonque (daraxonrasib), a first-in-class daily oral pill developed by Revolution Medicines for adults with advanced or metastatic pancreatic cancer.
7 minutes | Thursday, August 27, 2026
The FDA recently approved Rasonque (daraxonrasib), a first-in-class daily oral pill developed by Revolution Medicines for adults with advanced or metastatic pancreatic cancer.